KIR3DL3 Silencing Relieves B7H7-Mediated Suppression and Enhances CAR-T Cell Therapy in Pancreatic Cancer
Molecular Therapy Oncology · 2026-11 · 201397
DOI: 10.1016/j.omton.2026.201397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy Oncology, 2026-11. Verfasst von Mansur Dabai Salisu und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Salisu, M. D., Saliu, M. A., Liu, X., Xiao, A., Xu, Y., Suleiman, R. B., Liang, W., Adeshakin, A. O., Babarinde, I. A., He, Z., Liu, M., & Wan, X. (2026). KIR3DL3 Silencing Relieves B7H7-Mediated Suppression and Enhances CAR-T Cell Therapy in Pancreatic Cancer. Molecular Therapy Oncology, 201397. https://doi.org/10.1016/j.omton.2026.201397
Vancouver
Salisu MD, Saliu MA, Liu X, Xiao A, Xu Y, Suleiman RB, et al. KIR3DL3 Silencing Relieves B7H7-Mediated Suppression and Enhances CAR-T Cell Therapy in Pancreatic Cancer. Molecular Therapy Oncology. 2026:201397. doi:10.1016/j.omton.2026.201397
BibTeX
@article{Salisu2026,
author = {Salisu, Mansur Dabai and Saliu, Muhammad Auwal and Liu, Xudong and Xiao, Aoyi and Xu, Yuanchun and Suleiman, Rabiatu Bako and Liang, Wei and Adeshakin, Adeleye O. and Babarinde, Isaac Adeyemi and He, Zongsheng and Liu, Maoxuan and Wan, Xiaochun},
title = {KIR3DL3 Silencing Relieves B7H7-Mediated Suppression and Enhances CAR-T Cell Therapy in Pancreatic Cancer},
journal = {Molecular Therapy Oncology},
year = {2026},
pages = {201397},
doi = {10.1016/j.omton.2026.201397}
}
EUVIMED